Axar.az
UP
13 July 2020


Congo to start using Johnson & Johnson Ebola vaccine

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Health authorities in the Democratic Republic of Congo will introduce a Johnson & Johnson Ebola vaccine in November in the country’s eastern provinces, to counter the current outbreak, they said.

Axar.az reports citing Reuters that the J&J vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people. It requires two injections eight weeks apart, unlike the Merck vaccine, which requires a single shot.

The first batch of 500,000 doses of the J&J vaccine should arrive in Congo next week, the authorities said in a statement. The inoculation process will start in Goma in early November and then be extended to other provinces.

Congolese health authorities had announced the deployment of the vaccine last month but had not specified when the campaign will take place.

Since it first started in August 2018, the Ebola outbreak has killed more than 2,100 people, second only to the 2013-16 outbreak in West Africa that killed more than 11,300.

Date
2019.10.14 / 18:53
Author
Axar.az
Comments
See also

Russian university: Clinical trials of COVID-19 vaccine completed

WHO reports single-day increase in coronavirus

WHO experts to visit China for COVID-19 investigation

WHO: Coronavirus situation has not weakened

Good news from the WHO: Post-Covid period is beginning

Iran's coronavirus cases exceed 250,000

Ilham Aliyev inaugurated a new substation - Photo

Pandemic peak yet to be reached, says WHO head

WHO has stopped testing these drugs

Global virus recoveries top 6M: John Hopkins University

Latest
 
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla